NEW YORK (GenomeWeb) – Instruments manufacturer Intellicyt announced today that it is teaming up with oncology clinical lab Notable Labs to develop a predictive personalized medicine platform to help clinicians make treatment decisions for cancer patients.

Notable Labs will integrate Intellicyt's iQue Screener Plus platform into a fully automated, high-throughput lab to immune-profile phenotypic and functional endpoints of cells and secreted proteins through cell- and bead-based assays. Treatment options in order of priority will then be sent to clinicians.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.